SI-BONE, Inc. (SIBN)
23.44
-0.70
(-2.90%)
USD |
NASDAQ |
Nov 13, 16:00
23.43
-0.01
(-0.04%)
Pre-Market: 19:59
SI-BONE Enterprise Value : 951.45M for Nov. 13, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 13, 2026 | 951.45M |
| November 12, 2026 | 982.96M |
| November 11, 2026 | 1.019B |
| November 10, 2026 | 1.026B |
| November 09, 2026 | 1.049B |
| November 06, 2026 | 987.46M |
| November 05, 2026 | 988.81M |
| November 04, 2026 | 1.019B |
| November 03, 2026 | 966.31M |
| November 02, 2026 | 806.54M |
| October 30, 2026 | 851.99M |
| October 29, 2026 | 905.10M |
| October 28, 2026 | 879.00M |
| October 27, 2026 | 861.44M |
| October 26, 2026 | 855.59M |
| October 23, 2026 | 863.24M |
| October 22, 2026 | 866.84M |
| October 21, 2026 | 833.54M |
| October 20, 2026 | 820.94M |
| October 19, 2026 | 781.34M |
| October 16, 2026 | 782.24M |
| October 15, 2026 | 792.59M |
| October 14, 2026 | 772.78M |
| October 13, 2026 | 782.24M |
| October 12, 2026 | 801.14M |
| Date | Value |
|---|---|
| October 09, 2026 | 768.28M |
| October 08, 2026 | 745.33M |
| October 07, 2026 | 756.13M |
| October 06, 2026 | 776.38M |
| October 05, 2026 | 788.09M |
| October 02, 2026 | 710.23M |
| October 01, 2026 | 725.08M |
| September 30, 2026 | 742.63M |
| September 29, 2026 | 752.81M |
| September 28, 2026 | 735.37M |
| September 25, 2026 | 727.77M |
| September 24, 2026 | 724.65M |
| September 23, 2026 | 728.22M |
| September 22, 2026 | 737.61M |
| September 21, 2026 | 721.52M |
| September 18, 2026 | 705.43M |
| September 17, 2026 | 703.19M |
| September 16, 2026 | 725.54M |
| September 15, 2026 | 725.99M |
| September 14, 2026 | 732.69M |
| September 11, 2026 | 718.39M |
| September 10, 2026 | 714.81M |
| September 09, 2026 | 719.73M |
| September 08, 2026 | 729.12M |
| September 04, 2026 | 723.75M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Globus Medical, Inc. | 9.161B |
| Abbott Laboratories | 215.41B |
| AngioDynamics, Inc. | 480.34M |
| Alphatec Holdings, Inc. | 1.622B |
| AtriCure, Inc. | 2.804B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -3.62M |
| Revenue (Quarterly) | 55.70M |
| Total Expenses (Quarterly) | 59.32M |
| EPS Diluted (Quarterly) | -0.0806 |
| Gross Profit Margin (Quarterly) | 79.29% |
| Profit Margin (Quarterly) | -6.50% |
| Earnings Yield | -1.32% |
| Normalized Earnings Yield | -1.318 |